These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 24781450

  • 1. Hypertriglyceridemia and hyperglycemia induced by capecitabine: a report of two cases and review of the literature.
    Han GH, Huang JX.
    J Oncol Pharm Pract; 2015 Oct; 21(5):380-3. PubMed ID: 24781450
    [Abstract] [Full Text] [Related]

  • 2. Capecitabine-induced hypertriglyceridemia: a report of two cases.
    Koutras AK, Habeos IG, Vagenakis AG, Kalofonos HP.
    Anticancer Res; 2006 Oct; 26(3B):2249-51. PubMed ID: 16821596
    [Abstract] [Full Text] [Related]

  • 3. Capecitabine-induced severe hypertriglyceridemia: report of two cases.
    Kurt M, Babaoglu MO, Yasar U, Shorbagi A, Guler N.
    Ann Pharmacother; 2006 Feb; 40(2):328-31. PubMed ID: 16391007
    [Abstract] [Full Text] [Related]

  • 4. Capecitabine-induced hypertriglyceridemia and hyperglycemia: two cases.
    Duman BB, Paydas S, Tetiker T, Gunaldı M, Afsar CU, Erçolak V, Haksöyler V, Dilli MŞ.
    Pharmacology; 2012 Feb; 90(3-4):212-5. PubMed ID: 23038659
    [Abstract] [Full Text] [Related]

  • 5. Uncontrolled hypertriglyceridemia induced by capecitabine: case report and review of the literature.
    Bar-Sela G, Haim N.
    Cancer Chemother Pharmacol; 2009 Apr; 63(5):779-82. PubMed ID: 18641989
    [Abstract] [Full Text] [Related]

  • 6. Cancer chemotherapy and cardiovascular risks: is capecitabine-induced hypertriglyceridemia a rare adverse effect?
    Seminara P, Losanno T, Emiliani A, Manna G.
    Cardiology; 2010 Apr; 116(1):42-4. PubMed ID: 20431291
    [Abstract] [Full Text] [Related]

  • 7. 5-Fluorouracil Induced Hypertriglyceridemia During the Colorectal Cancer Treatment in a Patient With Multifactorial Chylomicronemia Syndrome: A Case Report.
    Penesova A, Minarik P, Huckova M, Vlcek M, Szantova M, Krizanova O.
    Clin Ther; 2024 May; 46(5):429-432. PubMed ID: 38763818
    [Abstract] [Full Text] [Related]

  • 8. Hypertriglyceridemia in patients with metastatic breast cancer and treatment with capecitabine.
    Geva S, Lazarev I, Geffen DB, Ariad S.
    J Chemother; 2013 Jun; 25(3):176-80. PubMed ID: 23783143
    [Abstract] [Full Text] [Related]

  • 9. Increase in triglyceride blood level in patients treated with capecitabine: a retrospective survey.
    Bar-Sela G, Cohensius-Kent D, Vornikova O, Haim N.
    Anticancer Drugs; 2014 Jul; 25(6):729-34. PubMed ID: 24595094
    [Abstract] [Full Text] [Related]

  • 10. Severe sequence-specific toxicity when capecitabine is given after Fluorouracil and leucovorin.
    Hennig IM, Naik JD, Brown S, Szubert A, Anthoney DA, Jackson DP, Melcher AM, Crawford SM, Bradley C, Brown JM, Seymour MT.
    J Clin Oncol; 2008 Jul 10; 26(20):3411-7. PubMed ID: 18612156
    [Abstract] [Full Text] [Related]

  • 11. Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II study.
    Santini D, Vincenzi B, Schiavon G, Di Seri M, Virzí V, Spalletta B, Caricato M, Coppola R, Tonini G.
    Cancer Chemother Pharmacol; 2007 Apr 10; 59(5):613-20. PubMed ID: 16944151
    [Abstract] [Full Text] [Related]

  • 12. Capecitabine plus oxaliplatin for the first-line treatment of elderly patients with metastatic colorectal carcinoma: final results of the Southern Italy Cooperative Oncology Group Trial 0108.
    Comella P, Natale D, Farris A, Gambardella A, Maiorino L, Massidda B, Casaretti R, Tafuto S, Lorusso V, Leo S, Cannone M.
    Cancer; 2005 Jul 15; 104(2):282-9. PubMed ID: 15948167
    [Abstract] [Full Text] [Related]

  • 13. Hypertriglyceridaemia-induced pancreatitis: a contributory role of capecitabine?
    Chan HY, Ng CM, Tiu SC, Chan AO, Shek CC.
    Hong Kong Med J; 2012 Dec 15; 18(6):526-9. PubMed ID: 23223655
    [Abstract] [Full Text] [Related]

  • 14. The clinical importance of recognizing capecitabine-induced hypertriglyceridemia: A case report and review of the literature.
    Leung J, Brady JL, Crook MA.
    J Clin Lipidol; 2018 Dec 15; 12(6):1371-1373. PubMed ID: 30126762
    [Abstract] [Full Text] [Related]

  • 15. XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer.
    Cassidy J, Tabernero J, Twelves C, Brunet R, Butts C, Conroy T, Debraud F, Figer A, Grossmann J, Sawada N, Schöffski P, Sobrero A, Van Cutsem E, Díaz-Rubio E.
    J Clin Oncol; 2004 Jun 01; 22(11):2084-91. PubMed ID: 15169795
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Phase I pharmacokinetic study of chronomodulated dose-intensified combination of capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer.
    Farid M, Chowbay B, Chen X, Tan SH, Ramasamy S, Koo WH, Toh HC, Choo SP, Ong SY.
    Cancer Chemother Pharmacol; 2012 Jul 01; 70(1):141-50. PubMed ID: 22648745
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.